sentences:  Patient-reported outcomes are important in a regulatory context.The US Food and Drug Administration (FDA) has issued formal Guidance to Industry on PROs in label claims and the European Medicines Agency (EMA) has produced a reflection paper on HRQoL.Increasing numbers of regulatory submissions for new drugs provide PRO data to support claims.